BAX and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, b‐AP15 induced cleavage of PARP and caspase 3, as well as downregulation of Mcl‐1 and upregulation of Bax (Figure 6D), further supporting the anti‐cancer activities of b‐AP15 in CML.